Downregulated m⁵C regulator NSUN6 enhances proliferation, migration and affects immune regulation in ovarian cancer

Kuan Hu1, Wenjing Shi2, Zongjiang Zhou2

  • 1Department of Hepatobiliary Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.

Scientific Reports
|May 29, 2026
PubMed

Insights

The gene NSUN6 is downregulated in ovarian cancer (OC) and suppresses tumor growth and spread. Restoring NSUN6 may offer a new therapeutic strategy for OC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Ovarian cancer (OC) is a lethal gynecological malignancy with late diagnosis and high metastatic potential.
  • RNA 5-methylcytosine (m⁵C) modification is a key regulator in cancer, but the role of m5C-related genes like NSUN6 in OC is unclear.

Purpose of the Study:

  • To investigate the role of NSUN6 in ovarian cancer progression and its potential as a therapeutic target.

Main Methods:

  • Analysis of OC datasets from GEO database, Kaplan Meier plotter, Western Blot, immunohistochemical staining, cell line overexpression, CCK8, wound healing, Transwell assays, in vivo xenograft models, and bioinformatic analyses.

Main Results:

  • NSUN6 was significantly downregulated in OC and correlated with poorer prognosis, advanced tumor stage, metastasis, and survival.
  • NSUN6 overexpression inhibited OC cell proliferation, migration, and invasion by suppressing AKT phosphorylation.
  • In vivo studies confirmed NSUN6's tumor-suppressive effects, and bioinformatic analysis indicated enrichment in immune-related pathways.

Conclusions:

  • NSUN6 acts as a tumor suppressor in ovarian cancer by inhibiting AKT activity.
  • NSUN6 downregulation contributes to OC progression, and NSUN6 represents a potential therapeutic target for OC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...